Virtus' Management team has considerable experience in the Assisted Reproductive Services (ARS), diagnostics and day hospital markets around the world.
Kate Munnings, Group Chief Executive Officer
Kate commenced as Group CEO at Virtus Health Limited on 23 March 2020. A qualified lawyer and registered nurse, Kate’s diverse breadth of professional experience equips her to lead the Virtus Health team in continuing to provide their exceptional work that helps people become parents.
Prior to joining Virtus Health, Kate led significant operations including as Chief Operating Officer of Ramsay Health Care Limited’s 72 Australian hospitals; and as Chief Executive, Operations leading a portfolio of largely government contracts across Australia, New Zealand and Melanesia at Transfield Services Limited (now Broadspectrum Limited).
Kate has also been a partner at law firms Corrs Chambers Westgarth and Baker McKenzie; specialising in contract law and also spent eight years as Chief Risk & Legal Officer/Company Secretary at Transfield Services focused on commercial law, risk management and corporate governance.
As a registered nurse, Kate was one of the early specialist in HIV/AIDS nursing at Sydney’s St Vincent’s Hospital.
Kate is currently a Board member of the Digital Health Cooperative Research Centre and previously spent four years on the Board of South Eastern Sydney Local Health District.
Glenn Powers, Chief Financial Officer and Company Secretary
Glenn joined Virtus as CFO and Company Secretary in August 2008. Prior to joining Virtus, Glenn was CFO and Company Secretary of Tower Software Limited.
Glenn has a broad range of experience in private equity backed businesses, working in a range of engineering, electronics, software and service businesses. Glenn has also been a Director for both main and AIM market listed businesses in the UK. Glenn is a Chartered Management Accountant.
Teena Pisarev, Managing Director, NSW/ACT, Singapore and Diagnostics
Teena is an experienced executive, with a demonstrated history of working in the hospital & health care industry.
Skilled in strategic planning, business development, strategy, change management, and healthcare management, Teena has 23 years’ experience working across leadership roles managing the delivery of clinical services.
A strong business development professional, Teena graduated from Griffith University (AUS).
A/Prof Peter Illingworth, Medical Director, New South Wales
Peter joined Virtus in May 2006 and since that date has served as Medical Director of IVF Australia Pty Ltd along with providing contracted clinical services to patients of IVF Australia Pty Ltd.
Peter is an accredited specialist obstetrician and gynaecologist with over 20 years specialist experience in the area of infertility practice. Peter has an international reputation in the field of reproductive medicine.
Prior to joining Virtus, Peter was Network Director at the Women’s and Children’s Health, Director of Reproductive Medicine at Westmead Hospital and a Clinical Scientist at MRC Reproductive Biology Unit in Edinburgh, Scotland.
Peter is a Conjoint Honorary Associate Professor at Sydney University, a position he has held since 1996.
Jade Phelan, Managing Director, Victoria and Tasmania
Jade is a highly regarded healthcare executive with a unique combination of significant operational experience gained from managing in a large and complex private hospital environment and strong commercial acumen having begun her career in finance roles with two major accounting firms.
Jade worked at Healthscope Operations Limited for six years as the CEO of The Mount Private Hospital in WA, one of the largest Healthscope hospitals in the country, before returning home to Melbourne and commencing with Virtus in late 2016.
With a strong track record of thriving in a patient and doctor facing environment in specialist healthcare, Jade is a welcomed member of the executive team.
Dr Lyndon Hale, Medical Director, Victoria
Lyndon has been the Medical Director of Melbourne IVF Pty Ltd since 2008. He is also Director of Reproductive Surgery at The Women’s Hospital, and is on the board of the Fertility Society of Australia. Lyndon is highly regarded for his knowledge and proactive approach and brings extensive experience in assisted reproduction treatments to the care of his patients.
Dr Bill Watkins, Medical Director, Tasmania
Bill is currently Clinical Director of TasIVF, having been part of the TasIVF team since 1996. He is also the only CREI qualified fertility specialist in Tasmania. Bill was Senior Registrar at the Royal Women’s Hospital in Melbourne from 1993 until early 1996, where he was responsible for the IVF program and involved in establishing one of Australia’s first ICSI programs. He returned to Tasmania in 1996 and joined TasIVF, initially established as one of Australia's first IVF clinics by three gynaecoligists, including Bill's father.
Chris Smedley, Managing Director, Queensland
Chris Smedley joined Virtus Health in June 2020 to drive operational excellence across our fertility and day hospital businesses in Queensland. A seasoned executive with more than 20 years’ working in complex healthcare organisations, Chris has a strong track record in effective change management and growing revenue through creating positive, resilient workplace cultures.
With previous roles as Chief Executive Officer of Assure Programs and General Manager of BUPA, Queensland, Chris is purpose-driven, results-focused and skilled at harnessing employee engagement and customer experience to transform business and revenue growth.
A qualified Chartered Accountant and with a Bachelor of Engineering, Chris is a proven leader and a valuable addition to the Virtus Health executive team.
A/Prof Anusch Yazdani, Medical Director, Queensland
A/Prof Anusch Yazdani was appointed the Medical Director of Queensland Fertiity Group in 2019. He is a graduate of the University of Queensland (MBBS Hons), Anusch completed his specialisation in Obstetrics and Gynaecology (FRANZCOG) in Brisbane.
Following a fellowship in minimally invasive pelvic surgery in Sydney, A/Prof Yazdani returned to Brisbane in 2002 to develop tertiary referral units in minimally invasive surgery at the Royal Brisbane and Mater Hospitals. In 2006, he completed his subspecialisation in Reproductive Endocrinology and Infertility (CREI), resulting in the unique subspecialist qualifications in reproductive endocrinology, fertility and minimally invasive surgery.
A/Prof Yazdani is widely published in medical journals, has co-authored numerous textbooks and lectures widely nationally and internationally.
Dr David Molloy, Director Medical Affairs, Virtus Health
David was appointed as Director Medical Affairs in 2019 to identify and proactively manage Virtus Health's interests within the political, legislative and regulatory environment in which the ARS sector operates in Australia.
Serving as Medical Director of Queensland Fertility Group Pty Ltd in 2004 and providing contracted clinical services to patients of Queensland Fertility Group Pty Ltd since 1986, David has a distinguished resume of achievements, including acting as President of the Australian Medical Association in Queensland, Australian Gynaecological Endoscopy & Surgery Society Limited and National Association of Specialist Obstetricians and Gynaecologists as well as Chairman of the IVF Directors Group.
David also currently holds the position of Vice Chair of the IVF Directors Group, a position he has held since 2004.
Richard Banks, Group Chief Strategy Officer and Managing Director, Europe
Richard joined Virtus in August 2017 with a strong reputation in strategic planning, service transformation, operational turnaround, business development and program management. Richard has significant experience of working with Executive teams in healthcare organisations and enjoys both developing strategy and taking plans through to implementation.
Richard received his formal management training through the UK’s NHS Graduate Management Training Scheme and he has a Master’s degree in Healthcare Management and Leadership. He has worked as an NHS Director, Management Consultant and Private Hospital Director. Richard is a Fellow of the Chartered Management Institute and the Institute of Leadership and Management.
Richard plays a vital role in the expansion of Virtus operations within Europe.
Dr John Kennedy, Medical Director, Ireland
John was appointed Medical Director of the Virtus Sims Group in July 2017. In his role, John is responsible for Virtus Health’s full Irish medical team, leading and directing his team on all medical and clinical matters and all related communications.
John is also the appointed Responsible Person “RP” for all three Irish Clinics, a critical element of Virtus’ Irish operation.
Graduating from University College Dublin in 2000, John is a member of the Royal College of Physicians, Ireland. Prior to joining Sims as a consultant in 2013, John practised Obstetrics and Gynaecology throughout the Dublin maternity hospitals and has extensive experience in all aspects of his specialist field.
Dr Bjørn Bay, Medical Director, Aagaard Klinik
Joining Virtus in January 2020 as Medical Director Bjorn is a Medical Doctor and PhD with a special interest in assisted reproduction. Most recently Bjørn was a specialist IVF doctor at the regional Hospital Horsens Fertility Clinic which amalgamated with the Fertility Clinic at Aarhus University Hospital in 2016.
Bjorn has a special focus on the safety of the procedures and on selection, screening and safety of semen donations having been MD and Medical Director of Cyros International for a decade. Bjorn undertook specialist training at Aarhus University originally before post doctorate studies with the Centre for Family Research at University of Cambridge.
Dr Kåre Rygaard, Medical Director, Trianglen Denmark
Kåre is the Medical Director of Trianglen Fertility Clinic in Copenhagen. Partnering with the Virtus Health group in June 2018, Kåre is a specialist in advanced infertility treatment and all procedures related to infertility including IUI, IVF, ICSI and TESA.
Kåre first joined Trianglen Fertility Clinic as an external consultant in 2001. In 2005, he accepted a full-time position at the clinic and in 2012 became the owner of Trianglen.
Kåre studied medicine at the University of Copenhagen, graduating in 1987. Completing his thesis in 1993, Kåre undertook laboratory research on cancer related genes in small cell lung before becoming a specialist in obstetrics and gynaecology in 2000. Fascinated by the field of fertility, Kåre obtained further education from the fertility clinics at Rigshospitalet and Herlev Hospital, both of which are part of The Copenhagen University Hospital.
Professor Ying Cheong, Medical Director, Complete Fertility
Medical Director and Co-founder Complete Fertility is a Professor of Reproductive Medicine at the University of Southampton, a specialist in Fertility Medicine, laparoscopic and open fertility surgery, endometriosis, recurrent miscarriage, polycystic ovarian disease and adhesions.
Prof Ying is an active researcher, leading the clinical research network for Reproductive Health in Hampshire and Isle of Wight and, lectures around the world disseminating her research as editor and author to over 100 peer-reviewed papers, books and chapters. An educator of Undergraduate and Post-graduate medicine and other related biological sciences she continues to mentor clinicians of the future. In her daily practice, Prof Ying cares for both private and NHS patients.
Dr Ann Tan, Medical Director, Singapore
Dr Ann Tan brings a wealth of experience to the Virtus Group as the Medical Director of Virtus Fertility Centre Singapore and is responsible for the high level of medical standards, laboratory operations and treatment quality the centre provides.
Dr Tan has been the recipient of several prestigious awards in her field of specialization including the HMDP Scholarship for Fetal Echocardiography at Yale School of Medicine in 1995, the Young Investigator Award by the International Society of Ultrasound in Obstetrics & Gynaecology in 1995 and the Young Investigator Award at the International Scientific Meeting of Royal College of Obstetricians & Gynaecologists in 1993. She was also awarded the Public Service Medal for her contributions with the Singapore Council of Women’s Organisations in 2012. Dr Ann Tan has an interest in research focused on in optimising fertility and ovarian reserves.